Screener
Aquestive Therapeutics, Inc. AQST Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Aquestive Therapeutics, Inc.’s reported figures.
The source filing: Aquestive Therapeutics, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001398733-26-000042
FAQ
- What is Aquestive Therapeutics, Inc.'s free cash flow?
- Aquestive Therapeutics, Inc. (AQST) reported free cash flow of -$9.65M in Q2 2026.
- How has Aquestive Therapeutics, Inc.'s free cash flow changed year-over-year?
- Aquestive Therapeutics, Inc.'s free cash flow decreased by 20.3% year-over-year, from -$8.02M to -$9.65M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s free cash flow?
- Over 3 years (2021 to 2025), Aquestive Therapeutics, Inc.'s free cash flow has grown at a 16.1% compound annual growth rate (CAGR), from -$33.89M to -$52.99M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Aquestive Therapeutics, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude